Bifunctional Ligand Targeting Quorum-Sensing Peptides
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Biofilms formed by microorganisms on wounds and medical devices are resistant to antimicrobial treatments, making existing methods ineffective in inhibiting their formation and treatment.
Innovation Solution
A bifunctional ligand comprising a quorum-sensing-peptide-binding region and a protease-binding region is used to target and degrade quorum-sensing peptides, inhibiting biofilm formation and treatment on surfaces, including wounds and medical devices, potentially combined with antibiotics and reduced pressure therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antimicrobial treatments are used, then treatment simplicity is maintained, but treatment effectiveness deteriorates due to biofilm resistance
Solution Approach 1:
The patent introduces a bifunctional ligand as an intermediary substance that mediates between the protease enzyme and the quorum-sensing peptide target. The ligand contains a protease-binding region that specifically binds to protease and a quorum-sensing-peptide-binding region that binds to the peptide, thereby directing the protease to the target site within the biofilm. This intermediary approach enhances treatment effectiveness by ensuring precise targeting while maintaining relatively simple application procedures.
2Object-generated harmful factors
If bifunctional ligands are used to target quorum-sensing peptides, then biofilm formation is inhibited, but the complexity of the treatment increases
Solution Approach 1:
The patent merges multiple functional regions into a single bifunctional ligand molecule. The ligand combines a protease-binding region and a quorum-sensing-peptide-binding region into one unified structure, allowing it to simultaneously bind to both the enzyme and the target peptide. This merging approach enables the treatment to inhibit biofilm formation through a single applied substance rather than requiring separate components, thereby reducing operational complexity despite the sophisticated molecular design.
3Reliability
If proteases are applied directly, then quorum-sensing peptides can be degraded, but specificity is reduced leading to off-target effects
Solution Approach 1:
The patent applies the local quality principle by creating a treatment structure with differentiated functional regions. The bifunctional ligand has a protease-binding region with specific properties for enzyme binding and a quorum-sensing-peptide-binding region with specific properties for target recognition. This local differentiation ensures that the protease is directed specifically to the quorum-sensing peptide target within the biofilm, enhancing treatment specificity while maintaining a relatively simple overall treatment structure that can be applied as a single composition.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bifunctional ligand effectively inhibits biofilm formation and treatment by degrading quorum-sensing peptides, overcoming the resistance of biofilms to antimicrobial treatments and promoting wound healing.
Implementation Method 1
contacting a biofilm or a surface with a bifunctional ligand comprising a quorum-sensing-peptide-binding region and a protease-binding region, whereby the biofilm is treated
Data Source
AI summary
Methods and compositions for the treatment of biofilms and/or the inhibition of biofilm formation. In one embodiment, a biofilm is treated and/or biofilm formation is inhibited by a method comprising contacting a biofilm or a surface with a bifunctional ligand comprising a quorum-sensing-peptide-binding region and a protease-binding region, whereby the biofilm is treated and/or biofilm formation on the surface is inhibited.